Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    China unveils AI protein synthesis platform in Shanghai

    July 11, 2026

    Burjeel Holdings lists $500 million debut sukuk in London

    July 11, 2026

    flydubai to restart daily Dubai-Aleppo flights on July 20

    July 11, 2026
    Facebook X (Twitter) Instagram
    Quds Times: Jerusalem and Palestine, in context.Quds Times: Jerusalem and Palestine, in context.
    • Home
    • Contact Us
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Quds Times: Jerusalem and Palestine, in context.Quds Times: Jerusalem and Palestine, in context.
    Home » ZeptoMetrix Launches PROtrol: Quality Control Material for the Lateral Flow Immunoassay Market
    Featured News

    ZeptoMetrix Launches PROtrol: Quality Control Material for the Lateral Flow Immunoassay Market

    May 18, 2023
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Telegram Email

    BUFFALO, NY / ACCESSWIRE / May 16, 2023 / ZeptoMetrix® is excited to introduce PROtrol TM, a new line of products designed for antigen-based diagnostic methods. These third-party materials mimic a true clinical specimen and can be used to evaluate and monitor the performance of antigen-based assays, including lateral flow immunoassays for infectious diseases.

    ZeptoMetrix logo
    ZeptoMetrix logo

    PROtrol is the only whole organism reference material to provide complete testing data. Each lot of product is supplied with the protein concentration and TCID50 value, which minimizes qualification testing. PROtrol provides better reproducibility, which optimizes the use of financial spending and processing time through the decreased need for repeat testing.

    “The rapid expansion in development of antigen-based assays has highlighted some quality challenges. Inactivated, whole organism controls designed specifically for antigen tests can equip manufacturers with the tools they need to better evaluate the performance of their assays, leading to higher quality tests on the market,” said Dr. Karuna Sharma, Vice President & Chief Scientific Officer.

    PROtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Isolate: USA-WA1/2020* is the first member of this product line (PROSARS(COV2)-587). As we move beyond the COVID-19 pandemic, ZeptoMetrix will continue to grow the PROtrol product line, providing high-quality controls to assay manufacturers seeking to expand access to inexpensive and easy-to-use diagnostics.

    “The launch and expansion of PROtrol enhances our position as the partner of choice for diagnostic test developers,” said Evangeline Gonzalez, President of Antylia Diagnostics division. “As we work with our diagnostic partners, ZeptoMetrix is pleased with the role that PROtrol plays to give patients around the world more access to diagnostic testing.”

    More information on how to order the new PROtrol and additional ZeptoMetrix products can be found at: https://www.zeptometrix.com

    About ZeptoMetrix®
    ZeptoMetrix® is an established industry leader in the design, development, and delivery of innovative, quality solutions to the infectious disease diagnostics market. Our expertise and abilities in molecular diagnostics, including external quality controls, verification panels, proficiency panels, customized and OEM products/services have set the industry standard for performance and reliability and make ZeptoMetrix the preferred choice for independent third-party quality control materials.

    Links:
    * (PROSARS(COV2)-587): product page
    https://www.zeptometrix.com/products/protrolt-sars-cov-2-isolate-usa-wa1-2020-1-ml

    Contact Information

    Andrew Zenger
    Global Product Manager
    andrew.zenger@antylia.com
    (716) 715-7417

    Related Files

    PROSARS(COV2)-587 Product Insert.pdf
    ZeptoMetrix Launches PROtrol.pdf

    SOURCE: ZeptoMetrix

    .

    ZeptoMetrix Launches PROtrol: Quality Control Material for the Lateral Flow Immunoassay Market

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Truecaller Ads Launches ‘Call-to-Cart’, a New Commerce Surface Built on the Communication Layer

    June 17, 2026

    Al Naboodah Opens GWM’s Largest Overseas Showroom in the UAE

    June 16, 2026

    JustMarkets Research Highlights Global Growth Divergence as a Key Market Driver

    June 4, 2026

    Newszy relaunches for busy PR and marketing teams

    June 3, 2026

    Plekhanov University in Dubai Inaugurates R&D Center and Unveils New Patent and Two Revolutionary AI Technologies

    May 19, 2026

    Thumbay Group Breaks Ground on the Region’s First Private, Fully Integrated Psychiatric and Rehabilitation Hospital at Sharjah Healthcare City

    May 13, 2026
    Latest News
    Technology

    China unveils AI protein synthesis platform in Shanghai

    July 11, 2026

    Chinese researchers unveil an AI-assisted protein synthesis platform in Shanghai designed to produce up to 10,000 samples daily in one system.

    Burjeel Holdings lists $500 million debut sukuk in London

    July 11, 2026

    flydubai to restart daily Dubai-Aleppo flights on July 20

    July 11, 2026

    China halts helium exports under temporary trade order

    July 11, 2026

    OpenAI unveils GPT-5.6 models and Work agent

    July 10, 2026

    Apple expands Broadcom chip deal in U.S. manufacturing

    July 9, 2026

    ASEAN workforce faces broad GenAI exposure, ILO finds

    July 9, 2026

    ADB cuts Asia Pacific 2026 growth forecast to 4.9%

    July 9, 2026
    © 2026 Quds Times | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.